Soleno Therapeutics Inc (SLNO) — Cash Flow Reinvestment Rate
Soleno Therapeutics Inc (SLNO) has a Cash Flow Reinvestment Rate of 0.00x as of March 2026, reinvesting $40.00K (capex $40.00K ) from operating cash flow of $25.98 Million. Explore Soleno Therapeutics Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Soleno Therapeutics Inc Cash Flow Reinvestment Rate (2025–2025)
Historical reinvestment intensity for Soleno Therapeutics Inc across 1 annual periods. Also explore how large is Soleno Therapeutics Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Soleno Therapeutics Inc (2025–2025)
Year-by-year capital reinvestment analysis for Soleno Therapeutics Inc. For live market cap and broader valuation context, see Soleno Therapeutics Inc (SLNO) total market value.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 4.31x | $201.78 Million | $46.80 Million | $73.00K | — |